Novel Coronavirus (SARS-CoV-2/COVID-19)
The Centers for Disease Control and Prevention should appoint an independent panel to develop evidence-based practice guidelines for public health emergency preparedness and response and identify evidence gaps for future research, according to a report released by the National Academies of Sciences…
The Trump administration is poised to ask governors to consider sending in the National Guard to hospitals to help improve data collection about novel coronavirus patients, supplies and capacity, according to draft letters, internal emails and hospital sector officials familiar with the plans, the…
Following the announcement of changes to its process for collecting daily COVID-19-reated data from hospitals, the Department of Health and Human Services today asked hospitals to prioritize the reporting of seven data fields starting tomorrow, July 15:
Following yesterday’s announcement of changes to its process for collecting daily COVID-19-related data from hospitals, the Department of Health and Human Services (HHS) today asked hospitals to prioritize the reporting of seven data fields starting tomorrow, July 15.
Now more than ever, the leadership of nurses and physicians is invaluable to the teams, organizations and patients they serve. They help those around them keep perspective, and their vision and guidance pave the road to a healthier future.
At the peak of New York state’s COVID-19 outbreak, Montefiore Medical Center in the Bronx was at the epicenter. For the behavioral health center, that meant greatly expanding its already innovative use of digital solutions to connect with its patients. This would be needed to continue to serve the…
The Department of Health and Human Services (HHS) today
A social worker with the U.S. Army Reserve bonds with a 96-year-old patient, a veteran of World War II now fighting COVID-19.
Dartmouth-Hitchcock Health collaborates with community partners to improve food access during the COVID-19 pandemic.
The Food and Drug Administration authorized the University of California San Francisco’s Clinical Labs at China Basin to use a new molecular-based diagnostic test for SARS-CoV-2.